Recent Blog Articles
Is online gambling harming you?
Preventable liver disease is rising: What you eat — and avoid — counts
Fall shots: Who's most vulnerable to RSV, COVID, and the flu?
Got immunity? Thank your thymus
Easy ways to shop for healthful, cost-conscious foods
When — and how — should you be screened for colon cancer?
7 organs or glands you may do just fine without
How to help your child get the sleep they need
What color is your tongue? What's healthy, what's not?
Immune boosts or busts? From IV drips and detoxes to superfoods
Ameet Sarpatwari, JD, PhD
Contributing Editor
Ameet Sarpatwari is an Instructor in Medicine at Harvard Medical School and an Associate Epidemiologist at Brigham and Women’s Hospital based in the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes. Among other projects, he is currently examining the public health implications of variation in state drug product selection laws, the risk of re-identification under HIPAA pathways for data sharing for post-approval drug research, and the comparative safety and effectiveness of biosimilars.
